A Parakeet Owner's Pulmonary Puzzle: Severe Asthma, Sarcoidosis, and Allergic Bronchopulmonary Aspergillosis (ABPA) Complicated by Stenotrophomonas maltophilia and Hypersensitivity Pneumonitis
Abstract Introduction: Severe asthma complicated by allergic bronchopulmonary aspergillosis (ABPA), sarcoidosis, and bronchiectasis poses significant management challenges. We present a case of a 71-year-old male with a history of severe asthma on biologic therapy, who developed worsening dyspnea and was found to have Stenotrophomonas maltophilia. This case underscores the complexities of managing chronic respiratory diseases in patients with environmental exposures and highlights the role of hypersensitivity pneumonitis in overlapping pulmonary conditions. Case Report: A 71-year-old male with a history of sarcoidosis, severe persistent asthma on biologic therapy and home oxygen, ABPA, bronchiectasis (recently complicated by Proteus bronchitis treated with trimethoprim/sulfamethoxazole), morbid obesity, and obstructive sleep apnea presented with worsening dyspnea over 6 months. He had a remote smoking history, increasing oxygen requirements, and was on high-dose steroids, ipratropium-albuterol nebulizers, triple therapy inhaler, montelukast, tezepelumab, and omalizumab. Notably, he owned parakeets and previously had elevated IgE and positive Chlamydia psittacosis serologies. He was afebrile and mildly hypoxic on 4L nasal cannula. Exam revealed coarse lung sounds with expiratory wheezing. Labs were significant for mild leukocytosis and elevated serum IgE at 1964 IU/mL. A CT chest revealed upper lung-predominant bronchiectasis and tree-in-bud nodularity, suggestive of chronic infection or hypersensitivity pneumonitis. Respiratory pathogen panel, Chlamydia/Chlamydophila serum titers, and multiple opportunistic infectious markers were negative. Hypersensitivity pneumonitis panel showed elevated IgG to Alternaria alternata, Cladosporium herbarum, Penicillium notatum, and Phoma spp. Bronchoscopy revealed Aspergillus on cytology, with cultures growing Stenotrophomonas maltophilia and Aspergillus. His asthma regimen was continued with the addition of inhaled budesonide. He was initially treated with ceftriaxone and azithromycin, later switched to levofloxacin, and discharged on a 10-day course of minocycline with a prednisone taper. Discussion: This case highlights the complexities of managing severe asthma in patients with multiple comorbidities and environmental exposures. The patient's history of bird ownership and previous elevated IgE levels suggest a potential link to hypersensitivity pneumonitis, a condition often exacerbated by inhalation of organic antigens found in bird droppings and feathers. Furthermore, the development of Stenotrophomonas maltophilia and Aspergillus infections in this context emphasizes the importance of vigilant monitoring for opportunistic infections in immunocompromised patients. Biologic therapies, while effective for severe asthma, can increase susceptibility to infections, necessitating careful management of comorbid conditions. This case illustrates the need for a multidisciplinary approach in managing such patients, integrating pulmonology, infectious disease, and allergy expertise to optimize treatment outcomes and mitigate risks associated with environmental exposures.
Read more